Volume 83, Issue 4, Pages (April 2013)

Slides:



Advertisements
Similar presentations
Mechanism of Action of Colchicine in the Treatment of Gout
Advertisements

MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Volume 72, Issue 3, Pages (August 2007)
Volume 68, Issue 3, Pages (September 2005)
Volume 85, Issue 3, Pages (March 2014)
Volume 87, Issue 4, Pages (April 2015)
Volume 76, Issue 1, Pages (July 2009)
A crystal-clear mechanism of chronic kidney disease
Progranulin protects against renal ischemia/reperfusion injury in mice
Volume 80, Issue 12, Pages (December 2011)
Volume 76, Issue 11, Pages (December 2009)
Volume 77, Issue 12, Pages (June 2010)
Volume 82, Issue 11, Pages (December 2012)
Volume 82, Issue 8, Pages (October 2012)
Volume 85, Issue 5, Pages (May 2014)
Volume 79, Issue 8, Pages (April 2011)
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury  Marisa D. Covington,
Volume 81, Issue 3, Pages (February 2012)
Volume 88, Issue 3, Pages (September 2015)
Volume 58, Issue 6, Pages (December 2000)
Volume 75, Issue 10, Pages (May 2009)
Volume 75, Issue 2, Pages (January 2009)
Volume 84, Issue 5, Pages (November 2013)
Volume 82, Issue 10, Pages (November 2012)
Genistein protects the kidney from cisplatin-induced injury
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 79, Issue 10, Pages (May 2011)
Volume 73, Issue 5, Pages (March 2008)
Volume 85, Issue 1, Pages (January 2014)
Volume 65, Issue 6, Pages (June 2004)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 78, Issue 2, Pages (July 2010)
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 81, Issue 3, Pages (February 2012)
Volume 84, Issue 5, Pages (November 2013)
Volume 79, Issue 1, Pages (January 2011)
Volume 80, Issue 12, Pages (December 2011)
Volume 82, Issue 7, Pages (October 2012)
Volume 89, Issue 2, Pages (February 2016)
Volume 87, Issue 2, Pages (February 2015)
Volume 64, Issue 4, Pages (October 2003)
Volume 82, Issue 4, Pages (August 2012)
Volume 66, Issue 6, Pages (December 2004)
Volume 81, Issue 3, Pages (February 2012)
Volume 83, Issue 3, Pages (March 2013)
Volume 86, Issue 4, Pages (October 2014)
Volume 63, Issue 6, Pages (June 2003)
Volume 70, Issue 2, Pages (July 2006)
Volume 65, Issue 3, Pages (March 2004)
Volume 79, Issue 4, Pages (February 2011)
Volume 73, Issue 11, Pages (June 2008)
Carole Oudot, Anne D. Lajoix, Bernard Jover, Caroline Rugale 
Genetic deficiency of adiponectin protects against acute kidney injury
Macrophages and hypoxia in human chronic kidney disease
Volume 68, Issue 6, Pages (December 2005)
Volume 85, Issue 4, Pages (April 2014)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 75, Issue 6, Pages (March 2009)
Volume 67, Issue 4, Pages (April 2005)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 79, Issue 2, Pages (January 2011)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Endothelial cell activation
Volume 59, Issue 5, Pages (May 2001)
Volume 56, Issue 6, Pages (December 1999)
Volume 95, Issue 5, Pages (May 2019)
Volume 86, Issue 5, Pages (November 2014)
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,
Presentation transcript:

Volume 83, Issue 4, Pages 662-673 (April 2013) Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status  Yuko Nishi, Minoru Satoh, Hajime Nagasu, Hiroyuki Kadoya, Chieko Ihoriya, Kengo Kidokoro, Tamaki Sasaki, Naoki Kashihara  Kidney International  Volume 83, Issue 4, Pages 662-673 (April 2013) DOI: 10.1038/ki.2012.475 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Pathological changes in the tubulointerstitium and glomeruli (a-d) Masson-trichrome (Masson) staining showing renal tubulointerstitial morphology. Bar=50μm. (e-h) Periodic acid–Schiff (PAS) staining showing glomerular morphology. Bar=50μm. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. (i) Tubulointerstitial injury score, (j) tubulointerstitial fibrosis score, and (k) glomerular injury score; n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Comparison of oxidative lipid accumulation and mitochondrial function and morphology in vivo. (a-d) Immunohistochemical staining for hexanoyl lysine (HEL). Bar=100μm. (e-h) Cytochrome c oxidase (COX) activity staining. Bar=100μm. (i-l) Succinic dehydrogenase (SDH) activity staining. Bar=100μm. (m-p) Transmission electron microscopy (TEM) for the evaluation of mitochondrial morphology. BM, basement membrane; TL, tubular lumen. Bar=4μm. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. (q) Positive area of HEL staining. (r) Positive area of COX staining. (s) Positive area of SDH staining. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Changes in mitochondrial redox system determined in vivo. (a) Thioredoxin reductase (TrxRD) activity in the mitochondrial fraction samples of the kidney. (b) Superoxide dismutase (SOD) activity in the mitochondrial fraction samples of the kidney. (c) mRNA expression of TrxRD 2. (d) mRNA expression of SOD 2. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Expression of mitochondrial β-oxidation-related genes in vivo. mRNA expression of (a) short-chain acyl-coenzyme A dehydrogenase (SCAD), (b) medium-chain acyl-coenzyme A dehydrogenase (MCAD), (c) long-chain acyl-coenzyme A dehydrogenase (LCAD), and (d) very-long-chain acyl-coenzyme A dehydrogenase (VLCAD). ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Alteration in tubular macrophage infiltration. (a-d) Immunohistochemical staining for F4/80 in the renal cortex. Bar=50μm. (e) Number of F4/80-positive cells. (f) mRNA expression of monocyte chemotactic protein-1 (MCP-1). (g) mRNA expression of cluster of differentiation molecule 11b (CD11b). ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Evaluation of interleukin-18 (IL-18) expression in vivo. (a-d) Immunohistochemical staining for IL-18 in the renal cortex. Bar=50μm. (e) Number of IL-18 positive cells. (f) IL-18 content in kidney tissue. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Evaluation of inflammasome activation in vivo. (a) mRNA expression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain–containing-3 (NLRP3). (b) mRNA expression of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). (c) mRNA expression of pro-caspase-1 (casp-1). (d) Western blot analysis for renal ASC expression and casp-1 activation. (e) Relative expression of ASC protein expression to GAPDH protein expression. (f) Relative expression of casp-1 protein expression to pro-casp-1 protein expression. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 8 Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining. (a-d) Pyroptotic cells were detected using TUNEL staining. Bar=50μm. (e) Number of TUNEL-positive cells. ICGN, ICR-derived glomerulonephritis mice; ICR, ICR mice; OVX, ovariectomized ICGN mice; RAL, OVX mice treated with raloxifene. n=10 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. ICR. †P<0.05 vs. ICGN. ‡P<0.05 vs. OVX. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 9 Mitochondrial oxidative stress in albumin-stimulated tubular cells. MitoSOX staining for the evaluation of mitochondrial reactive oxygen species. (a) No treatment (CON), (b) stimulation with fatty acid-bearing human albumin (FA-Alb), (c) stimulation with FA-Alb with raloxifene (FA-Alb+RAL), (d) stimulation with FA-Alb+RAL and ICI 182780 (FA-Alb+RAL+ICI). Bar=10μm. (e) Relative fluorescence intensity of MitoSOX staining. n=6 in each group. Data are shown as mean± s.e.m. *P<0.05 vs. CON. †P<0.05 vs. FA-Alb. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 10 Nuclear factor-κB (NF-κB) activation in albumin-stimulated tubular cells. (a) Western blot analysis for phospho-IκB-α and NF-κB component p65 in the cytosolic fraction. (b) Relative IκB protein expression to CON. (c) Relative NF-κB p65 protein expression related to CON. CON, no treatment; FA-Alb, stimulation with fatty acid-bearing human albumin; FA-Alb+RAL, stimulation with FA-Alb and raloxifene; FA-Alb+RAL+ICI, stimulation with FA-Alb+RAL and ICI 182780. n=6 in each group. Data are shown as mean±s.e.m. *P<0.05 vs. CON. †P<0.05 vs. FA-Alb. Kidney International 2013 83, 662-673DOI: (10.1038/ki.2012.475) Copyright © 2013 International Society of Nephrology Terms and Conditions